Bisphenol A (BPA)

January 19th, 2010

The Infant Nutrition Council (INC) is aware of the latest report from the USA Food and Drug Administration (FDA), released on the 15th January 2010, suggesting that recent studies provide reason for some concern about the potential effects of Bisphenol A (BPA) on the brain, behaviour and prostate gland of fetuses, infants and children.

INC supports the FDA recommendation to continue to use infant formula “as the benefit of a stable source of good nutrition outweighs the potential risk from BPA exposure”.

INC and its member companies have been and will continue to work with FSANZ to understand the effects of BPA. INC and FSANZ are currently reviewing the latest developments from the United States so that industry is able to respond to this issue in an appropriate manner.

It should also be noted that the FDA “recognizes substantial uncertainties with respect to the overall interpretation of these studies and their potential implications for human health effects of BPA exposure”. Other studies indicate that if there is any risk, it is extremely minimal.

For more information about BPA see Food Standards Australia New Zealand (FSANZ).